68% of healthcare leaders optimistic about Trump’s price transparency order, survey finds

Sixty-eight percent of healthcare leaders from provider organizations are optimistic about the executive order signed by President Donald Trump June 24 related to price disclosure, according to a Reaction Data report.

Advertisement

Reaction Data, a an online healthcare research platform based in American Fork, Utah, surveyed nearly 300 C-suite executives, physicians, nurses and pharmacists and directors from  provider organizations about their opinions on the executive order.

Survey participants ranked the executive order on a six-point scale, with 1 being “I think it’s a horrible idea” and 6 being “I think it’s a great idea.”

Twenty-seven percent of survey participants said they think the executive order to improve price transparency is a great idea. Another 41 percent of participants were also on the optimism half of the scale.

Thirty-two percent of respondents were on the opposite half of the scale.

Read more about the survey here.

 

More articles on healthcare finance:

Tenet shares jump after Conifer spinoff
10 hospitals seeking RCM talent
Senate won’t vote on surprise-billing protections before August recess

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.